Researchers developed a smartphone app that could allow people to screen for Alzheimer's and other neurological diseases and disorders—by recording closeups of their eye. The app uses a smartphone's built-in cameras to measure changes in pupil size, which could be used to assess cognitive condition.
The cowpea mosaic virus has shown great promise as an experimental cancer immunotherapy for treating and preventing recurrence of various cancers. But just how the virus triggers such a potent anti-cancer immune response has remained a mystery. A new study digs deeper and provides answers.
Nanoengineering master’s student Tala Sidawi had her time in the sun at the 2022 edition of Research Expo. Sidawi took home the grand prize for her work to model how solar panels “breathe” water in real time.
How do the lungs develop after taking their first breaths outside the womb? What cellular events and changes early in life give rise to lung malfunction and disease? UC San Diego researchers developed a single-cell atlas of postnatal lung development that could help answer these questions.
Two bioengineers at the University of California San Diego will be inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Professors Stephanie Fraley and Prashant Mali are among the 153 new AIMBE Fellows of 2022.
New research led by bioengineers at the University of California San Diego could make it much simpler to repair disease-causing mutations in RNA without compromising precision or efficiency. The new RNA editing technology holds promise as a gene therapy for treating genetic diseases.
UC San Diego researchers have identified a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the genome. These mutation clusters contribute to the progression of about 10% of human cancers and can be used to predict patient survival.
A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer's disease.
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells.